Skip to content
GH SecretagogueWADA ProhibitedCompare

Sermorelin

Also known as: Geref, GRF 1-29

3
1 · Natty510 · Enhanced

Lower numbers = closer to natural. Higher numbers = more enhanced.

Why this rating?

Sermorelin is one of the earliest and most studied GHRH analogs, with a long history of clinical use. It stimulates natural pulsatile GH release rather than replacing GH directly. With a very safe side effect profile and prescription status, it represents a mild enhancement primarily used in anti-aging medicine. Effects are subtle and require 3-6 months of consistent use. Rated 3 as it works entirely through natural pathways with minimal intervention.

Overview

A peptide that stimulates the pituitary to release more GH in a natural pattern. One of the earliest and most studied GHRH analogs, commonly used in anti-aging and regenerative medicine.

Important Warnings

  • •Weaker and shorter-acting than Mod GRF 1-29: easily under-dosed if used alone rather than with a GHRP
  • •Contraindicated with active malignancy: GH/IGF-1 elevation can promote cell proliferation
  • •Now supplied mainly via compounding pharmacies/research sources. Quality varies
  • •WADA prohibited (S2 category, GHRH analogue): will cause a positive drug test

Purpose & Use Cases

Anti-Aging

Promotes natural GH production for anti-aging benefits.

Sleep Quality

Significantly improves sleep quality and depth.

Recovery

Enhances recovery and regeneration.

Benefits

  • Natural GH release pattern
  • Improved sleep quality
  • Enhanced recovery
  • Anti-aging effects
  • Very safe profile
  • Long history of clinical use

Good to Know

The original GHRH analog

Sermorelin (GRF 1-29) is the oldest and most-studied GHRH analog. It was FDA-approved as Geref for diagnosing and treating childhood GH deficiency, then withdrawn from the US market in 2008, for business/manufacturing reasons, not safety (the FDA formally determined it was not withdrawn for safety or effectiveness).

Stimulates your own GH, not a replacement

It binds pituitary GHRH receptors to trigger natural, pulsatile GH release and a modest IGF-1 rise. Because it works within physiological feedback loops, effects are subtle and build over 3-6 months of consistent nightly dosing.

Shortest half-life: very physiological but easily under-dosed

At ~10-20 minutes, Sermorelin has the shortest half-life of the GHRH analogs. It lacks the amino-acid substitutions of Mod GRF 1-29, so it is degraded quickly by DPP-4 and is weaker/shorter-acting, one reason many users prefer Mod GRF or pair Sermorelin with a GHRP.

Best paired with a GHRP

GHRH analogs and GHRPs act through different mechanisms, so combining Sermorelin with Ipamorelin or a GHRP produces a much larger, synergistic GH pulse than Sermorelin used alone.

One of the safest GH peptides: no PCT

Side effects are rare and mild (transient flushing, occasional headache), glucose impact is minimal at physiological GH output, and it does not suppress the testosterone axis, so no PCT is needed. Inject fasted, before bed, for best results.

Dosage Guidelines

Experience LevelDosage Range
Beginner200 – 300 mcg/day
Intermediate300 – 400 mcg/day
Advanced400 – 500 mcg/day
Frequency
Once-daily subcutaneous injection before bed, on an empty stomach; some protocols cycle 5 days on/2 days off to limit GHRH-receptor desensitization
Typical Cycle Length
12 – 26 weeks
Notes

The 200-500mcg/day range is off-label, community/clinic dosing for adult GH support, not a clinical trial-derived figure, the historical FDA-approved (Geref) label dose for pediatric GH deficiency was weight-based at 0.03mg/kg (30mcg/kg) SC nightly. Best results with consistent use over 3-6 months; a break of several weeks is often taken between cycles to let IGF-1 normalize and reduce receptor desensitization.

Side Effects

Headache

uncommon
Severity
1/5

Occasional headaches, especially when starting.

Mitigation

Usually transient; reduce dose if persistent.

Flushing

uncommon
Severity
1/5

Temporary facial flushing after injection.

Mitigation

Normal and transient.

Dizziness

rare
Severity
1/5

Occasional lightheadedness.

Mitigation

Take before bed to avoid issues.

Nausea

uncommon
Severity
1/5

Mild, transient nausea reported after injection in some users.

Mitigation

Usually resolves on its own; injecting fasted before bed tends to minimize it.

General Mitigation Strategies

Nighttime administration helps avoid any dizziness. One of the safest peptides available. Side effects are rare and mild.

Post Cycle Therapy (PCT)

✓PCT Not Required

Does not suppress natural hormone production. No PCT required.

How It Works

Sermorelin is a truncated analog of GHRH (growth hormone releasing hormone) containing the first 29 amino acids. It stimulates the pituitary gland to produce and release growth hormone in a natural, pulsatile manner.

Fundamentals

Reference on the practices relevant to Sermorelin: how they are done and where they go wrong. Not a recommendation to use it.

Reconstitution & concentration math→

Turning this powder into a measured dose

Sterile technique & injection-site infection→

Avoiding abscesses and cellulitis

Bloodwork: what to measure and when→

The markers that matter here

Warning signs & when to seek care→

When to stop and get help

Common Stacks

  • Sermorelin + GHRP-6 - Enhanced GH release
  • Sermorelin + Ipamorelin - Synergistic stack

WADA Status

⛔Prohibited by WADA
Category: S2. Peptide Hormones, Growth Factors, Related Substances and Mimetics
In-Competition: ProhibitedOut-of-Competition: Prohibited

Sermorelin is prohibited at all times under WADA category S2 as a growth hormone-releasing hormone (GHRH) analogue.

References

Last updated: July 18, 2026